PEGS Europe Conference

14th November 2022

16th November 2022

Barcelona, Spain

Quality Assistance is participating to the PEGS Europe Conference

Join us at the Protein & Antibody Engineering Summit, in Barcelona. It will be the perfect time and place to discuss how we can help you with the development of your products.

We are a benchmark CRO when it comes to analytical expertise in proteins and antibodies.

19 years’ experience with NBEs

To accelerate the development and marketing of your NBEs, Quality Assistance offers a complete analytical package to meet the EMA and FDA requirements, all on one site.

14 years’ experience with antibody-drug conjugates

Thanks to our combined experience with small molecule cytotoxics and monoclonal antibodies, we can provide full analytical support for your ADCs projects. We offer a wide range of services for all payload categories (maytansine derivatives, auristatins, etc.) and all conjugation strategies (lysine, cysteine, site-specific).

17 years’ experience with monoclonal Antibodies

Take no risk with your analytics when developing new therapeutic monoclonal antibodies. Our analytical teams take advantage of their extensive experience with the analysis of mAbs.

Throughout non-clinical and clinical development, our experts provide you with the customised solutions in terms of analytical protocols and innovative technologies to help you move your product from discovery to the market place.

WHY PARTNER WITH QUALITY ASSISTANCE?

With more than 40 years’ experience, Quality Assistance is a leading analytical CROs and holds a unique position on the market with all its laboratories on one site and 240 highly qualified professionals.

MEET US AT our BOOTH

You want to know more about Quality Assistance? Meet Cécile Montage and Louis Lefebvre, Key Account Managers during the event.

Poster session

Cécile Montagne and Louis Lefebvfire will benet from the event to present our latest researches. Make sure to join them during the poster's session on 15th November.
They will present the following poster:

Development and Validation of an Antibody-Drug Conjugate Bioassay